A potential mechanism linking VEGF inhibitors to cerebral infarction is the inhibition of VEGF receptors (VEGFR) signaling, leading to increased vasoconstriction through reduced nitric oxide and prostacyclin production, which can cause hypertension [4,29,30]. This evidence concerns the gene KDR and hypertensive disorder.